Strain deposit number: ATCC53103
Lactobacillus rhamnosus GG (trademark LGG®) has been widely tested in more than 160 clinical studies from newborn preterm infants to elderly in doses up to at least 100 billion CFU/day with no reported side effects. Lactobacillus rhamnosus GG is considered safe based on its long history of use for human consumption and thorough safety studies.
Human studies indicate that Lactobacillus rhamnosus GG may have a beneficial effect within gastrointestinal and immune function:
We have gathered abstracts of the studies, supporting the effects of Lactobacillus rhamnosus GG (trademark LGG®) in our Selected Summaries below.
For more information please visit http://valio.com/solutions/valio-lgg/. LGG® is a registered trademark of Valio Ltd., Finland.
Contact Chr. Hansen's dedicated sales department - they will help you find the perfect product with strains from Chr. Hansen's Probio-Tec® range.
* Vanderhoof et al. 1999
** de Vrese et al. 2005
*** Hojsak et al. 2010a
**** Hojsak et al. 2010b